Previous 10 | Next 10 |
2023-04-18 21:21:06 ET Pressure BioSciences, Inc. (PBIO) Q4 2022 Earnings Conference Call April 18, 2023 04:30 PM ET Company Participants Richard Schumacher - President and Chief Executive Officer John Hollister - Director of Marketing and Sales Jeff Peterson - B...
Agreement Between Leading Companies in High-Pressure and Process Engineering/Equipment Technologies Will Deliver Immediate Upgrade to PBIO's Manufacturing Capacity. Agreement Also Offers Potential for Long-Term Equipment Manufacturing and Supply Relationship. SOUTH EASTON, MA / ACCE...
2023-04-14 12:18:55 ET Pressure BioSciences press release ( OTC:PBIO ): Q4 GAAP EPS of -$0.38. Revenue of $0.61M (+90.6% Y/Y). For further details see: Pressure BioSciences GAAP EPS of -$0.38, revenue of $0.61M
Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, has scheduled a conference call for Tuesday, April 18, 2023; to begin at 4:30 p.m. ET. The focus of the call will be to di...
Company Pivots Strongly into Revolutionary UltraShear Platform, Achieving Measurable Progress and Traction, Including Expected Record Revenue in Q1 2023 Investor Call Scheduled for Tuesday, April 18, 2023 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / April 14, 2023 / Pressure BioScien...
Conference Call Scheduled for Tuesday, April 18 at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / April 13, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fiscal Year 2022 financial results and to...
Pressure BioSciences (OTCQB: PBIO) , a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, has renewed its partnership with NutraLife Biosciences (OTC: NLBS) , a highly respected manufacturer and distributor of n...
PBIO's Patented UltraShear Nanoemulsification Platform is Centerpiece of Renewed Collaboration SOUTH EASTON, MA / ACCESSWIRE / April 6, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-bas...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries. The company, together with its wholly owned subsidiary PBI Agrochem Inc., today announ...
PBI Agrochem Ships and Bills Initial $130,000 Eco-Friendly Agrochem Order in New Demand Pipeline SOUTH EASTON, MA / ACCESSWIRE / March 28, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-b...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...